What Is Atazanavir?

Atazanavir is a prescription HIV protease inhibitor. It is FDA-approved for treating HIV-1 infection in adults and in children at least 3 months old who weigh at least 11 pounds, or 5 kilograms. It must be used with other antiretroviral medicines rather than as a one-drug HIV treatment.

HIV uses an enzyme called protease to cut long viral proteins into smaller pieces that can be assembled into mature, infectious virus particles. Atazanavir blocks this enzyme. The virus may still produce unfinished particles, but they are less able to mature and spread efficiently. Think of it as stopping a factory at the final assembly line: plenty of parts may be lying around, but the finished product cannot roll out properly.

Atazanavir lowers HIV viral load but does not eliminate the virus from the body. Treatment must continue as prescribed, even when a person feels well or has an undetectable viral load. Consistent antiretroviral therapy can help people with HIV remain healthy, and maintaining an undetectable viral load prevents sexual transmission of HIV.

Is atazanavir still commonly used?

Atazanavir remains an approved treatment option and may still be appropriate for selected patients, including people who are stable on an effective regimen or whose resistance history and medical needs favor a protease inhibitor. However, current U.S. HIV guidelines generally favor second-generation integrase inhibitor regimens for most people starting treatment. Boosted atazanavir-based combinations are no longer preferred as routine initial therapy because newer options often offer easier dosing, fewer interactions, and better tolerability.

Atazanavir Uses

The primary use of atazanavir is the treatment of HIV-1 infection in combination with other antiretroviral agents. Its goals include:

• Reducing the amount of HIV circulating in the blood
• Helping the immune system recover or remain strong
• Lowering the risk of opportunistic infections and other HIV-related complications
• Supporting long-term viral suppression
• Reducing the chance that HIV develops resistance when the complete regimen is taken consistently

Atazanavir is not a cure for HIV, not a stand-alone treatment, and not a medication that should be borrowed, shared, or added to an existing regimen without specialist review. HIV treatment is less like choosing a vitamin and more like assembling a very particular orchestra. Every medication needs to enter at the correct time and avoid hitting the tuba player with a chair.

Atazanavir Dosing

Atazanavir dosing must be prescribed by an HIV specialist or another qualified clinician. The correct regimen depends on previous HIV treatment, resistance testing, other medications, age, weight, pregnancy, kidney function, liver function, and the use of ritonavir or cobicistat as a pharmacokinetic booster.

Typical adult dosing

Unboosted atazanavir is not recommended for treatment-experienced adults. Dosing during pregnancy and pediatric treatment follows additional rules, and some combinations require dosage changes or should be avoided entirely.

Pediatric dosing

Children may receive capsules or oral powder depending on age, weight, swallowing ability, and treatment history. FDA-labeled pediatric doses are weight-based and generally include ritonavir. The oral powder may be used in children at least 3 months old who weigh at least 5 kilograms. Atazanavir is not recommended in babies younger than 3 months because elevated bilirubin could increase the risk of kernicterus, a serious neurological condition.

Liver and kidney considerations

People with liver disease may need an adjusted regimen or a different HIV medicine. Unboosted atazanavir is not recommended in severe liver impairment, while atazanavir combined with ritonavir is generally not recommended in people with any degree of hepatic impairment under the FDA labeling.

Kidney dose adjustment is not usually required in people who are not receiving hemodialysis. However, atazanavir has been associated with kidney stones, crystal-related kidney injury, and chronic kidney disease. Treatment-experienced patients with end-stage kidney disease managed with hemodialysis should not receive Reyataz.

How to Take Atazanavir Correctly

• Take atazanavir once daily at approximately the same time.
• Always take it with food to improve absorption.
• Swallow capsules whole. Do not open, crush, or chew them.
• Take ritonavir at the same time when it is part of the prescribed regimen.
• Use the oral powder exactly as instructed and consume the entire mixture within one hour.
• Do not stop atazanavir or any other HIV medicine without guidance from the prescribing clinician.

Stopping doses, frequently taking them late, or running out of medication can allow HIV to reproduce and may contribute to drug resistance. Set a phone reminder, use a weekly medication organizer when appropriate, and request refills before the bottle begins making that alarming hollow rattle.

What if you miss a dose?

Take the missed dose when you remember it. When it is already close to the time of the next scheduled dose, skip the forgotten dose and return to the regular schedule. Do not take two doses at once to compensate. Contact the HIV care team when doses are missed repeatedly or when vomiting prevents medication from staying down.

Atazanavir Pictures and Pill Identification

Brand-name Reyataz capsules have specific colors and imprints, although generic atazanavir capsules may look different depending on the manufacturer.

• Reyataz 200 mg: Blue cap and blue body, marked “BMS 200 mg” and “3631” in white ink.
• Reyataz 300 mg: Red cap and blue body, marked “BMS 300 mg” and “3622” in white ink.
• Reyataz oral powder: Supplied in packets containing 50 mg of atazanavir.

Never identify a medication by color alone. Lighting, counterfeit products, generic manufacturers, and the impressive ability of blue capsules to resemble other blue capsules can all create confusion. Confirm the imprint, strength, pharmacy label, manufacturer, and prescription information. Ask a pharmacist before taking any loose or unidentified capsule.

Common Atazanavir Side Effects

Not everyone experiences side effects, and some problems improve as the body adjusts. Commonly reported reactions include:

• Nausea or vomiting
• Stomach discomfort or diarrhea
• Headache or dizziness
• Muscle aches
• Trouble sleeping
• Mild rash
• Yellowing of the eyes or skin

In clinical studies, nausea, jaundice or yellowing of the whites of the eyes, and rash were among the most common adverse reactions in adults starting treatment. Treatment-experienced adults also commonly reported jaundice and muscle pain.

Why can atazanavir cause yellow eyes?

Atazanavir commonly increases indirect bilirubin by blocking an enzyme involved in bilirubin processing. This may cause yellow skin or yellowing of the whites of the eyes, called scleral icterus. The bilirubin increase is usually reversible after discontinuation and does not automatically mean that the liver has been injured.

However, jaundice should still be reported. A clinician may need to distinguish expected indirect hyperbilirubinemia from hepatitis, bile duct disease, gallstones, or another liver problem. Yellowing accompanied by dark urine, pale stools, vomiting, appetite loss, fever, or upper-right abdominal pain deserves prompt evaluation.

Serious Atazanavir Warnings

Abnormal heart rhythm

Atazanavir may prolong the PR interval, slowing electrical conduction through part of the heart. Extra caution may be required in people with existing conduction disorders or those taking other medicines that affect heart rhythm. Seek urgent care for fainting, severe dizziness, an unusually slow heartbeat, or a new irregular heartbeat.

Severe skin reactions

Mild rashes can occur, but rare severe reactions have included Stevens-Johnson syndrome, erythema multiforme, toxic skin eruptions, and DRESS syndrome. Blistering, peeling skin, mouth sores, facial swelling, fever, painful eyes, or a rapidly spreading rash requires immediate medical attention.

Liver injury

Patients with hepatitis B, hepatitis C, existing liver disease, or elevated liver enzymes may have a greater risk of worsening liver abnormalities. Liver tests are generally checked before treatment and monitored during therapy.

Kidney and gallbladder stones

Kidney stones and gallstones have been reported, sometimes requiring hospitalization. Warning signs include severe side or back pain, blood in the urine, painful urination, fever, nausea, or intense pain in the upper-right abdomen.

High blood sugar

Protease inhibitor treatment has been associated with new or worsening diabetes and hyperglycemia. Excessive thirst, frequent urination, unusual hunger, blurred vision, or unexplained weakness should be reported.

Immune reconstitution inflammatory syndrome

As antiretroviral therapy strengthens the immune response, the body may begin reacting to previously hidden or quiet infections. New swelling, fever, respiratory symptoms, neurological problems, or worsening signs of an existing infection should be evaluated rather than dismissed as “the medicine finally kicking in.”

Phenylketonuria

Reyataz oral powder contains phenylalanine from aspartame. People with phenylketonuria must discuss this with their care team. The capsules do not contain phenylalanine.

Major Atazanavir Drug Interactions

Atazanavir is metabolized primarily through CYP3A and can also inhibit enzymes and transporters that process other medications. Ritonavir increases atazanavir exposure but adds another substantial layer of interaction risk. A complete medication review should include prescriptions, over-the-counter products, vitamins, recreational substances, and herbal supplements.

Acid-reducing medications

Atazanavir needs stomach acid for reliable absorption. Proton pump inhibitors, H2 blockers, antacids, and buffered medications can lower atazanavir levels.

• Antacids and buffered medicines are generally taken at least two hours before or one hour after atazanavir.
• H2 blockers such as famotidine require dose limits and carefully planned separation.
• Proton pump inhibitors are not recommended in treatment-experienced patients taking atazanavir.
• In selected treatment-naive adults, a limited PPI dose may be allowed approximately 12 hours before boosted atazanavir.

Do not invent a timing schedule from memory. The instructions differ according to treatment history, booster use, tenofovir use, and the specific acid-reducing product.

Examples of medicines that may be contraindicated

The following list is not complete, but important examples include:

• Rifampin
• St. John’s wort
• Simvastatin and lovastatin
• Oral midazolam and triazolam
• Carbamazepine, phenytoin, and phenobarbital
• Nevirapine
• Sildenafil when used as Revatio for pulmonary arterial hypertension
• Certain ergot medications
• Pimozide
• Selected hepatitis C combinations, including glecaprevir/pibrentasvir

Atazanavir may also raise concentrations of erectile dysfunction medicines, some calcium channel blockers, immunosuppressants, corticosteroids, sedatives, anticoagulants, and cholesterol-lowering drugs. The result may be dangerously low blood pressure, muscle injury, excessive sedation, abnormal bleeding, heart rhythm problems, or other toxicity. Conversely, enzyme-inducing drugs can reduce atazanavir levels and allow HIV resistance to develop.

Pregnancy, Birth Control, and Breastfeeding

Atazanavir may be used during pregnancy when clinically appropriate, but it must be combined with ritonavir under the FDA-labeled pregnancy regimen. Dosage changes may be necessary during the second or third trimester when tenofovir disoproxil fumarate or an H2 blocker is also used.

Atazanavir may affect hormonal contraceptives, and ritonavir can create additional interactions. Patients should ask their HIV and reproductive health clinicians which contraceptive methods are suitable rather than assuming that every pill, patch, ring, implant, or injection will maintain the same effectiveness.

Breastfeeding recommendations for people with HIV depend on individual circumstances, viral suppression, local guidance, access to safe alternatives, and shared decision-making. Discuss feeding plans with an HIV specialist before delivery and whenever treatment or viral load changes.

Monitoring During Atazanavir Treatment

Monitoring may include:

• HIV viral load and CD4 cell count
• Kidney function and urinalysis
• Liver enzymes and bilirubin
• Blood glucose
• Cholesterol and triglycerides
• Electrocardiogram testing in patients with conduction risks
• Resistance testing when viral suppression is not achieved or maintained

An increasing viral load does not always mean that atazanavir has suddenly “stopped working.” Missed doses, poor absorption, interactions with heartburn medication, resistance, vomiting, and problems with the companion drugs all need to be investigated.

Frequently Asked Questions

Can atazanavir be taken without ritonavir?

Some treatment-naive adults who cannot tolerate ritonavir may receive unboosted atazanavir 400 mg once daily. Most treatment-experienced patients and several other clinical groups require boosted treatment. The decision belongs to the prescribing specialist.

Does atazanavir cure HIV?

No. It suppresses HIV as part of combination antiretroviral therapy. Treatment must continue to maintain control of the virus.

Can I take omeprazole with Reyataz?

Sometimes it is prohibited, and in limited treatment-naive situations a restricted dose and strict separation may be permitted. Ask the HIV pharmacist or prescriber before using omeprazole, esomeprazole, pantoprazole, lansoprazole, or another proton pump inhibitor.

Is yellowing of the eyes dangerous?

It is often caused by an expected increase in indirect bilirubin and may not represent liver damage. Nevertheless, the care team should be informed, particularly when jaundice is new, severe, distressing, or accompanied by other symptoms.

Can I drink alcohol while taking atazanavir?

Alcohol does not create one simple, universal interaction rule, but it can worsen liver disease, interfere with adherence, increase dizziness, and complicate blood sugar or lipid control. Discuss an appropriate limit with the treating clinician, especially with hepatitis or other liver problems.

Conclusion

Atazanavir is an effective HIV protease inhibitor when it is used as one part of a carefully selected antiretroviral regimen. It is usually taken once daily with food and is often boosted with ritonavir. Its best-known side effect is increased bilirubin, which can produce yellow eyes or skin, but its most important safety concerns include drug interactions, severe rash, liver problems, kidney disease, stones, abnormal cardiac conduction, and high blood sugar.

The medication is not a casual “take one and see what happens” prescription. Heartburn products, supplements, cholesterol drugs, seizure medicines, sedatives, hepatitis treatments, and even St. John’s wort can significantly alter its safety or effectiveness. The safest approach is beautifully unglamorous: take every dose correctly, keep an updated medication list, complete laboratory monitoring, and contact the care team before changing anything.

Practical Experiences and Lessons From Atazanavir Treatment

The following situations are illustrative composites based on common medication-management issues rather than accounts of specific identifiable patients.

Experience 1: The surprising mirror moment

A person may begin atazanavir, feel physically well, and then notice that the whites of the eyes look yellow in the bathroom mirror. The first thought is often, “My liver is failing,” followed closely by an internet search capable of turning mild concern into a full-scale disaster movie.

Atazanavir-related indirect bilirubin elevation is common and may occur without liver damage. Still, the practical lesson is not to self-diagnose it as harmless. The clinic may check bilirubin fractions, liver enzymes, urine color, abdominal symptoms, and hepatitis history. When tests support isolated indirect hyperbilirubinemia, the medication may continue. When the cosmetic change is distressing or affects quality of life, switching regimens may be discussed. A side effect does not have to be medically dangerous to be personally difficult.

Experience 2: The innocent heartburn medicine

Another frequent problem begins at a grocery store. A patient develops heartburn, buys an over-the-counter acid reducer, and takes it every morning. No warning bells ring because the product is available without a prescription and looks about as threatening as a mint.

Weeks later, laboratory testing shows an unexpected rise in viral load. The problem may not be missed atazanavir doses at all; reduced stomach acidity may have lowered drug absorption. The experience highlights why “over the counter” does not mean “interaction free.” Pharmacists should know about every heartburn tablet, antacid chew, buffered product, vitamin, supplement, and herbal remedy. Photographing product labels and showing them during an appointment is often more reliable than remembering something was “a white bottle with a purple stripe.”

Experience 3: Building the dose around real life

Taking atazanavir with food sounds simple until work shifts, travel, nausea, parenting, and unpredictable meal times join the conversation. A dose scheduled with a large breakfast may work beautifully at home but collapse during a week of early flights and hotel coffee.

A practical plan connects the medication to a meal that happens consistently. The meal does not need to win a cooking competition, but it should satisfy the prescribing instructions. A travel supply should remain in original labeled containers, with extra doses packed in carry-on luggage rather than checked baggage. Phone alarms can include the words “with food” instead of merely making an unexplained noise at 7:00 p.m.

Experience 4: The medication list that prevents trouble

Atazanavir interactions often become complicated when several specialists are involved. A cardiologist may prescribe one medicine, a psychiatrist another, and a primary care clinician a statin, while nobody realizes an herbal supplement has quietly joined the team.

The most useful habit is maintaining one current list containing drug names, strengths, dosing times, supplements, as-needed medicines, and the exact HIV regimen. Share it at every appointment and pharmacy visit. This small administrative chore can prevent dangerous sedation, muscle injury, heart rhythm problems, treatment failure, and avoidable dose changes.

Experience 5: A detectable viral load is a question, not a verdict

When viral load becomes detectable, patients may fear that they have failed treatment. Clinicians instead review the situation systematically: adherence, food intake, vomiting, refill history, acid-reducing drugs, new prescriptions, resistance results, and whether all companion medicines were taken correctly.

The lesson is to report problems honestly. Missing doses because of cost, side effects, depression, unstable housing, privacy concerns, or an impossible schedule is a healthcare problem that deserves a practical solutionnot a courtroom confession. Successful HIV treatment depends on a regimen that works both in laboratory theory and in an actual human life.